Clinical observations on the sequencial TACE, TSAI, and PVE treatment in advanced hepatocellular carcinoma with portal vein tumor thrombius
- VernacularTitle:THAE、TSAI、PVE序贯治疗伴门静脉癌栓晚期肝癌的临床研究
- Author:
Zhijian YU
;
Xianyong MENG
;
Jianping CHEN
- Publication Type:Journal Article
- Keywords:
Transcatheter hepatic arterial embolization(THAE), transcatheter superior mesenteric or splenic arterial infusion(TSAI), portal venous em-bolization(PVE), hepatocellular carcinoma(HCC), intraportal vinous tumor thrombi.
- From:
Chinese Journal of Digestion
1996;0(S1):-
- CountryChina
- Language:Chinese
-
Abstract:
The earliest and the most common metastasis of hepatocellular carcinoma (HCC) occur in the intrahepatic portal venous system, which indicates its worst prognosis. In 28 HCC patients with intraportal tumor thrombus, we employed 2 procedures, ie. the transcatheter hepatic arterial embolization(THAE), transcatheter superior mesenteric or splenic arterial infusion (TSAI) and portal vein embolization (PVE) in 12 cases, and THAE alone in 16 cases. In the former group, tumor size reduced more than 50% in 8 cases (partial remission PR), in particular tumor thrombus disappeared in 3 and decreased in size in 8; whereas in the latter group, PR was achieved in 3 only, without change size of the intraportal tumor thrombus in all 16 cases (P
